IL6 and metabolic dysfunction-associated steatotic liver disease: According to PPI network analyses, TNF, IL6, AKT1, ACTB, IL1B, PPARG, PPARA, LPL, ESR1, and PTGS2 were the top 10 targets for HJJPD to treat NAFLD.